Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

4.9K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
Abnormal Proliferation02:23

Abnormal Proliferation

4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Negative Regulator Molecules01:23

Negative Regulator Molecules

35.9K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.9K
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

5.7K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.7K
DNA Damage can Stall the Cell Cycle02:37

DNA Damage can Stall the Cell Cycle

9.3K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.3K
Cadherins in Tissue Organization01:19

Cadherins in Tissue Organization

3.1K
The cadherins are a superfamily of cell adhesion molecules comprising over 180 variants, with specific tissues expressing a particular combination of cadherin types. Cadherins generally exhibit homophilic binding; i.e., cadherins on one cell bind to cadherins of the same or closely related type on another cell. Thus, cells of the same type have a specific affinity to bind to each other and sort themselves into clusters to form tissues.
Cell Sorting During Development
Cell sorting plays an...
3.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pdcd4-Rictor Interaction Suppresses PFKFB3 to inhibit Tumorigenesis.

Research square·2026
Same author

Translational Inhibition of Slug by Pdcd4 Contributes to Invasion Inhibition in Colorectal Cancer Cells.

Cancer medicine·2025
Same author

The kinase PLK1 promotes Hedgehog signaling-dependent resistance to the antiandrogen enzalutamide in metastatic prostate cancer.

Science signaling·2025
Same author

The Impact of Pdcd4, a Translation Inhibitor, on Drug Resistance.

Pharmaceuticals (Basel, Switzerland)·2024
Same author

Platycodin D induces apoptosis through JNK1/AP-1/PUMA pathway in non-small cell lung cancer cells: A new mechanism for an old compound.

Frontiers in pharmacology·2022
Same author

Emodin-8-O-β-D-glucopyranoside, a natural hydroxyanthraquinone glycoside from plant, suppresses cancer cell proliferation via p21-CDKs-Rb axis.

Toxicology and applied pharmacology·2022

Related Experiment Video

Updated: Sep 5, 2025

Fluorescence-based Monitoring of PAD4 Activity via a Pro-fluorescence Substrate Analog
08:37

Fluorescence-based Monitoring of PAD4 Activity via a Pro-fluorescence Substrate Analog

Published on: November 5, 2014

10.0K

Dissecting the Roles of PDCD4 in Breast Cancer.

Qian Cai1,2, Hsin-Sheng Yang3, Yi-Chen Li4

  • 1Department of Geriatric Medicine, Qilu Hospital of Shandong University, Jinan, China.

Frontiers in Oncology
|July 7, 2022
PubMed
Summary

Programmed cell death 4 (PDCD4) suppresses tumor growth and its reduced expression is linked to breast cancer progression and drug resistance. Restoring PDCD4 levels may improve patient survival and treatment outcomes.

Keywords:
PDCD4breast cancerdrug resistancetranslational controltumor suppressor

More Related Videos

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
11:13

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

1.7K
High-Throughput Dissociation and Orthotopic Implantation of Breast Cancer Patient-Derived Xenografts
06:06

High-Throughput Dissociation and Orthotopic Implantation of Breast Cancer Patient-Derived Xenografts

Published on: December 20, 2024

725

Related Experiment Videos

Last Updated: Sep 5, 2025

Fluorescence-based Monitoring of PAD4 Activity via a Pro-fluorescence Substrate Analog
08:37

Fluorescence-based Monitoring of PAD4 Activity via a Pro-fluorescence Substrate Analog

Published on: November 5, 2014

10.0K
Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
11:13

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

1.7K
High-Throughput Dissociation and Orthotopic Implantation of Breast Cancer Patient-Derived Xenografts
06:06

High-Throughput Dissociation and Orthotopic Implantation of Breast Cancer Patient-Derived Xenografts

Published on: December 20, 2024

725

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Programmed cell death 4 (PDCD4) is a tumor suppressor protein that inhibits translation.
  • PDCD4 expression is frequently downregulated in breast cancer, correlating with tumor progression and proliferation.
  • Loss of PDCD4 is implicated in drug resistance and poor prognosis in breast cancer patients.

Purpose of the Study:

  • To investigate the role of PDCD4 in breast cancer progression, drug resistance, and as a prognostic marker.
  • To explore regulatory mechanisms controlling PDCD4 expression in breast cancer.
  • To evaluate the therapeutic potential of targeting the microRNA/PDCD4 axis.

Main Methods:

  • Gene mapping of PDCD4 to chromosome 10q24.
  • Analysis of PDCD4 protein structure and function in translation inhibition.
  • Investigation of PDCD4 regulation by non-coding RNAs, signaling pathways (MAPK, AKT), and HER2 activation.
  • Correlation analysis of PDCD4 expression with patient survival and drug resistance.

Main Results:

  • PDCD4 inhibits protein translation by interacting with translation initiation factors and mRNA.
  • PDCD4 expression is decreased in breast cancer due to various regulators, including miR-21.
  • HER2 activation downregulates PDCD4, contributing to aromatase inhibitor resistance.
  • Reduced PDCD4 expression is significantly associated with shorter overall survival in breast cancer patients.

Conclusions:

  • PDCD4 is a critical tumor suppressor in breast cancer, inhibiting proliferation and progression.
  • Modulating the microRNA/PDCD4 axis presents a potential strategy to overcome chemoresistance.
  • PDCD4 serves as an independent prognostic marker for breast cancer, with its downregulation indicating a poor outlook.